Sattva Sukun Lifecare Limited (formerly Mayukh Dealtrade Limited) has informed BSE Limited about its upcoming board meeting scheduled for Saturday, February 14, 2026. The meeting will be held at the company's registered office located at Office No. 101 on 1st Floor, Crystal Rose C.H.S Datta Mandir Road, Mahavir Nagar, Kandivali West Mumbai 400067.

Board Meeting Agenda

The board meeting has been convened pursuant to Regulation 29 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015. The meeting will address several key matters:

Regulatory Compliance

The company has notified the exchange about the implementation of trading window restrictions in accordance with insider trading regulations. The trading window for dealing in company securities by designated persons and their immediate relatives was closed from January 01, 2026.

Trading Window Details

Company Information

Sattva Sukun Lifecare Limited operates under CIN L51219MH1980PLC329224 and trades on BSE with scrip code 539519 under the script ID SATTVASUKU. The company secretary Poonam Rani has signed the official communication to the stock exchange regarding this board meeting schedule.

The meeting follows standard regulatory procedures for quarterly financial result announcements, ensuring compliance with SEBI listing regulations and maintaining transparency with stakeholders and investors.

Sattva Sukun Lifecare Limited , formerly known as Mayukh Dealtrade Limited, has reported a delay in filing its financial results for the quarter and half-year ended September 30, 2025. The company attributes this delay to the recent acquisition of a subsidiary, Pavapuri Export Private Limited, during the reporting period.

Reasons for Delay

The company cited several factors contributing to the postponement:

1. Subsidiary Acquisition: The acquisition of Pavapuri Export Private Limited necessitated the preparation of consolidated financial statements.
2. Integration Process: The following steps were required for proper integration:
   • Verification and alignment of accounting policies and reporting frameworks
   • Preparation and validation of consolidated accounts
   • Review of financial data and reconciliations
   • Finalization of consolidated financial statements

Timeline of Events

Company's Statement

In a clarification to the BSE Limited, Sattva Sukun Lifecare emphasized that the delay was unintentional and solely due to procedural and consolidation requirements arising from the new subsidiary acquisition. The company stated that it remains committed to statutory compliance and timely disclosures in accordance with SEBI regulations.

Impact and Compliance

While the delay in filing financial results is a deviation from the standard reporting timeline set by SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has taken steps to address the issue:

1. Provided a detailed explanation to the stock exchange
2. Submitted the financial results along with the Limited Review Report post-approval

Investors and stakeholders should note that such delays, while not ideal, can occur during significant corporate actions like acquisitions. The company's transparency in explaining the delay and its commitment to regulatory compliance are positive signs for maintaining investor trust.

As the financial data is not readily available, investors are advised to review the complete financial results once they are publicly disclosed to assess the company's performance and the impact of the new subsidiary on its financials.